High‐mobility group box 1 released by autophagic cancer‐associated fibroblasts maintains the stemness of luminal breast cancer cells

Cancer stem cells/cancer‐initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer‐associated fibroblasts (CAFs) are major components of the niche of breast cancer‐initiating cells (BCICs), and their interactions may profoundly...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pathology Vol. 243; no. 3; pp. 376 - 389
Main Authors Zhao, Xi‐Long, Lin, Yong, Jiang, Jun, Tang, Zhuo, Yang, Shuai, Lu, Lu, Liang, Yan, Liu, Xue, Tan, Jiao, Hu, Xu‐Gang, Niu, Qin, Fu, Wen‐Juan, Yan, Ze‐Xuan, Guo, De‐Yu, Ping, Yi‐Fang, Wang, Ji Ming, Zhang, Xia, Kung, Hsiang‐Fu, Bian, Xiu‐Wu, Yao, Xiao‐Hong
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.11.2017
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cancer stem cells/cancer‐initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer‐associated fibroblasts (CAFs) are major components of the niche of breast cancer‐initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross‐talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule‐associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high‐mobility group box 1 (HMGB1), which activated its receptor, Toll‐like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1–TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
The authors contributed in the following way: X-LZ, YL: performed most of the experiments and wrote the manuscript; LL, SY: performed the lentivirus and adenovirus infection; XL, JJ, YL, TJ: collected the clinical specimens; X-GH, Z-XY, QN: prepared the reagents; W-JF: performed the western blotting; X-HY, Y-FP, D-YG: performed the immunohistochemical scoring; X-HY, X-WB: performed data analysis; J-MW, XZ: edited and revised the manuscript; X-HY, H-FK, X-WB: designed the study, revised the manuscript, and provided administrative management.
Author contributions statement
ISSN:0022-3417
1096-9896
1096-9896
DOI:10.1002/path.4958